DATA SHEET DILZEM - Medsafe
DATA SHEET . DILZEM Diltiazem hydrochloride 30 mg & 60 mg tablets. Presentation . DILZEM 30 mg Tablet: Diltiazem HCl 30 mg is a white, circular, film-coated…
Download DATA SHEET DILZEM - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
AUSTRALIAN PRODUCT INFORMATION PANADOL …
www.medicines.org.au1 australian product information panadol osteo (paracetamol) tablets 1 name of the medicine paracetamol 2 qualitative and quantitative composition
REVISION OF MONOGRAPH ON TABLETS - World …
www.who.intDocument QAS/09.324/Final March 2011 REVISION OF MONOGRAPH ON TABLETS Final text for addition to The International Pharmacopoeia This monograph was adopted by the Forty-fourth WHO Expert Committee on
Lorvacs XL 1.5 mg Prolonged-release Tablets PL …
www.mhra.gov.ukMHRA PAR; LORVACS XL 1.5 MG PROLONGED-RELEASE TABLETS, PL 27900/0001 2 LORVACS XL 1.5 MG PROLONGED-RELEASE TABLETS PL 27900/0001 LAY SUMMARY The Medicines and Healthcare products Regulatory Agency (MHRA) granted a
MATERIAL SAFETY DATA SHEET - Pfizer
www.pfizer.comMATERIAL SAFETY DATA SHEET _____ Symptoms and Effects of Exposure: For information on potential signs and symptoms of exposure, See Section 2 - Hazards Identification and/or Section 11 - Toxicological Information.
Metformin Hydrochloride Extended-Release …
lupinpharmaceuticals.comPage 1 of 22 Metformin Hydrochloride Extended-Release Tablets 500 mg and 1000 mg Rx only DESCRIPTION Metformin hydrochloride extended-release tablets contain an oral antihyperglycemic drug used in
UK Public Assessment Report - GOV.UK
www.mhra.gov.ukUKPAR Sukkarto SR 500 mg and 1000mg prolonged release tablets PL 20117/0110-0111 1 UK Public Assessment Report Sukkarto SR 500 mg and 1000 mg prolonged release
MOTILIUM 10 mg Tablets - Janssen
www.janssen.com1 MOTILIUM (170928) PPI MOTILIUM 10 mg Tablets PRODUCT INFORMATION. NAME OF THE MEDICINE . Domperidone Domperidone has the following chemical structure. C …
Prolonged-release film-coated tablets - Medicines
www.medicines.org.au3 50 mg dose, the mean difference from placebo on QTcI interval at 5 hours post dose was 3.67 ms (upper bound of the one-sided 95% CI 5.72 ms).
NEW ZEALAND DATA SHEET NAME OF MEDICINE
www.medsafe.govt.nz11 An increased number of ECL cells possibly related to the increased serum gastrin levels, and .
Related search queries
Panadol, Tablets, REVISION OF MONOGRAPH ON TABLETS, World, Mg Prolonged-release Tablets PL, MG PROLONGED-RELEASE TABLETS, PL 27900, MG PROLONGED-RELEASE TABLETS PL 27900, MATERIAL SAFETY DATA, Pfizer, Metformin, Release, Release tablets, UK Public Assessment Report, Prolonged release tablets, Prolonged release, MOTILIUM 10 mg Tablets, Prolonged-release film-coated tablets, NEW ZEALAND DATA SHEET NAME OF MEDICINE